Results 41 to 50 of about 8,522 (180)

Safety of alteplase intravenous thrombolysis and influencing factors of clinical outcome in elderly patients with acute ischemic stroke

BMC Neurology
Objective To explore the safety of intravenous thrombolysis with alteplase (rt-PA) in the treatment of acute ischemic stroke (AIS) in the elderly (≥ 80 years old) and with analyze the influencing factors of its clinical outcome.
Yongyin Zhang, Lifen Chi, Hao Shu, Qiang Zhou, Shunkai Zhang, Xuerong Huang, Xiaoyi Song   +6 more
doaj   +1 more source

A fibrin targeted molecular imaging evaluation of microvascular no‐reflow in acute ischemic stroke

Brain and Behavior, 2022
Objective To investigate the relationship between fibrin deposition and “no‐reflow” within microcirculation after thrombolysis in acute ischemic stroke (AIS).
Xi Chen, Jing Wang, Liang Ge, Gang Lu, Hailin Wan, Yeqing Jiang, Zhenwei Yao, Gang Deng, Xiaolong Zhang   +8 more
doaj   +1 more source

Transcranial Histotripsy Clot and Tissue Ablation for Intracerebral Hemorrhage Evacuation and Other Brain Applications

, 2023
STROKE: Vascular and Interventional Neurology, EarlyView.
Jonathan Sukovich, Zhen Xu, Aditya S. Pandey   +2 more
wiley   +1 more source

Personification of the approaches to reperfusion therapy of ischemic stroke

Анналы клинической и экспериментальной неврологии, 2017
Introduction. Systemic thrombolytic therapy using recombinant tissue plasminogen activator (rtPA) is the gold standard of reperfusion therapy in certainpatients with ischemic stroke during the first 4.5 h after stroke onset. Objective.
Maksim A. Domashenko, Marina Yu. Maksimova, Marina E. Gafarova, Marine M. Tanashyan, Kseniya V. Antonova, Mikhail A. Piradov   +5 more
doaj   +1 more source

Multi‐Module Micro/Nanorobots for Biomedical and Environmental Remediation Applications

Advanced Intelligent Systems, EarlyView.
Multi‐module microrobots (MNRs) have overcome the limitations of single‐module systems by integrating components such as propeller, actuator, manipulator, and imaging modalities. They show promise in biomedical applications, such as targeted drug delivery and tissue repair, as well as in environmental remediation, including pollutant removal.
Bairong Zhu, Amar Salehi, Lei Xu, Wei Yuan, Tingting Yu   +4 more
wiley   +1 more source

Half-dose thrombolytic therapy in patients with right heart thrombi

Journal of International Medical Research, 2019
The management of floating right heart thrombi (FRHT) in patients with acute pulmonary emboli is controversial. Several recent case series have revealed similar efficacy and better survival rates with systemic thrombolytic therapy than with surgery.
Jamal Moosavi, Omid Shafe, Azin Alizadehasl, Mozhgan Parsaee, Anita Sadeghpour, Fahimeh Khesali, Hamid Reza Pouraliakbar, Kiara Rezaei Kalantari, Melody Farrashi, Mehrdad Jafari Fesharaki, Parham Sadeghipour   +10 more
doaj   +1 more source

Complications of thrombolysis in an intensive care unit

Acta Medica Lituanica, 2012
Background. Thrombolysis is often the only way in treating people with life-threatening conditions, like acute myocardial infarction (AMI), pulmonary embolism (PE) and acute ischemic stroke (AIS).
Živilė Deimantavičienė, Nerijus Klimas, Aurimas Pečkauskas, Giedrė Bakšytė, Andrius Macas, Linas Pieteris, Aurelija Repšienė   +6 more
doaj   +1 more source

Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region

Рациональная фармакотерапия в кардиологии, 2018
Aim. To study data on prehospital thrombolytic therapy in ST elevation myocardial infarction (STEMI) in the Perm Krai, its efficacy and safety.Material and methods.
S. A. Naumov, N. S. Karpunina
doaj   +1 more source

Does a History of Migraine Affect the Rate of Thrombolysis in Young Stroke Patients?

Stroke Research and Treatment, 2013
Background. Migraine is prevalent in young patients and a frequent stroke mimic. To distinguish stroke mimics from true stroke can be difficult, and there is a possibility of misdiagnosing a stroke as a migrainous attack in patients with migraine.
Halvor Øygarden, Christopher Elnan Kvistad, Lars Thomassen, Ulrike Waje-Andreassen, Halvor Naess   +4 more
doaj   +1 more source

Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia

Journal of Vascular Surgery Cases and Innovative Techniques, 2017
A patient's refusal to receive blood products can pose both clinical and ethical challenges to the surgeon. In this report, we review the case of a Jehovah's Witness presenting with critical lower limb ischemia and severe anemia for whom the decision of ...
Jeremy D. Kauffman, MD, T. Joseph Watson, MD, Joseph J. Campbell, MD   +2 more
doaj   +1 more source